News

Kenyan Infant with Rare Disorder Treated Successfully in India

Doctors at Fortis Memorial Research Institute, Gurugram, performed a life-saving bone marrow transplant, making it the first documented successful case of its kind in the country.

• By PharmaNews Live Desk
• New Delhi
• Nov 18, 2024

News

In a landmark medical achievement, a 14-month-old Kenyan infant diagnosed with Pearson Syndrome, a rare and life-threatening genetic disorder, has been successfully treated in India. Doctors at Fortis Memorial Research Institute, Gurugram, performed a life-saving bone marrow transplant, making it the first documented successful case of its kind in the country.

Pearson Syndrome, which affects only 1 in a million people globally, causes severe anemia, organ failure, and growth issues. Most children with the condition do not survive beyond their first year. Baby Arianna, who had been battling the disorder since birth, was brought to India after medical treatments in Kenya failed to stabilize her condition.

A Rare Diagnosis, a Unique Treatment

At Fortis Gurugram, genetic and bone marrow tests confirmed the diagnosis of Pearson Syndrome. Given the lack of a matching donor, doctors used stem cells from Arianna’s mother, a half-matched donor, to perform the transplant.

“This was an extremely complex case, as the survival rates for Pearson Syndrome are very low,” said Dr. Vikas Dua, who led the treatment. “Using a half-matched donor and an advanced chemotherapy plan, we were able to give Arianna a fighting chance. It has been over four months since the procedure, and she is recovering well.”

The transplant was conducted alongside multidisciplinary care from specialists, addressing the multi-organ impacts of the disorder. Since the procedure, Arianna has shown significant improvement, requiring no further transfusions and gradually gaining weight.

India’s Role in Advanced Healthcare

Arianna’s recovery highlights India’s growing prominence as a hub for complex medical procedures, attracting patients from around the world. Affordable costs, cutting-edge medical expertise, and state-of-the-art facilities are making India a preferred destination for medical tourism. 

“This case reflects India’s capabilities in handling even the rarest medical challenges,” said Yash Rawat, Facility Director at Fortis Gurugram. “Our goal is to deliver world-class care to patients, no matter where they come from.” For Arianna’s family, the successful treatment has been life-changing. “The doctors gave my daughter a second life,” her mother said with gratitude.

India’s success in this case reinforces its position as a leader in global healthcare innovation, offering hope to families facing rare and challenging medical conditions.